Drug intelligence / Profile preview

Der f

Development stage
Unknown
Lead developer
University of North Carolina at Chapel Hill
Administration
Inhalation
01

Overview

Der f (Dermatophagoides farinae) is a biological allergen extract derived from the American house dust mite. In the context of clinical research at the University of North Carolina, Chapel Hill, it is utilized as an inhaled challenge agent to identify asthmatic individuals who exhibit a late-phase asthmatic response (LPAR). The mechanism of action involves the cross-linking of allergen-specific Immunoglobulin E (IgE) antibodies bound to high-affinity receptors (FcεRI) on the surface of mast cells and basophils. This cross-linking triggers the degranulation of these cells, releasing potent inflammatory mediators such as histamine, leukotrienes, and cytokines. These mediators cause acute bronchoconstriction (the early-phase response) and subsequent airway inflammation and remodeling (the late-phase response). This screening process is essential for phenotyping subjects for inclusion in studies evaluating novel asthma therapeutics.

Other names
Dermatophagoides farinaeAmerican house dust mite allergen extractDer f-University of North Carolina, Chapel Hill
02

Targets

HDM-specific IgE (House dust mite-specific immunoglobulin E)

Beyond the preview

Go deeper on Der f.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Der f.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call